$SNBP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Panbela Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Panbela Therapeutics, Inc.. Get notifications about new insider transactions in Panbela Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 1,000 | 0 | 0 | 1,000 to 0 (-100.00 %) |
| Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 3,284 | 0 | 46,284 | 43 K to 46.3 K (+7.64 %) |
| Jun 11 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Gift | G | 0.00 | 7,142 | 0 | 1,000 | 8.1 K to 1,000 (-87.72 %) |
| Apr 01 2021 | SNBP | Panbela Therapeuti ... | Simpson Jennifer K. | President and CEO | Option Exercise | A | 4.09 | 170,000 | 695,300 | 170,000 | |
| Apr 01 2021 | SNBP | Panbela Therapeuti ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 4.09 | 40,000 | 163,600 | 40,000 | |
| Apr 01 2021 | SNBP | Panbela Therapeuti ... | Gagnon Suzanne | Director | Option Exercise | A | 4.09 | 35,000 | 143,150 | 35,000 | |
| Apr 01 2021 | SNBP | Panbela Therapeuti ... | Cullen Michael T. | Executive Chairman | Option Exercise | A | 4.09 | 55,000 | 224,950 | 55,000 | |
| Dec 03 2020 | SNBP | Panbela Therapeuti ... | MATHIESEN JEFFREY S | Director | Grant | A | 0.00 | 2,875 | 0 | 5,875 | 3 K to 5.9 K (+95.83 %) |
| Dec 03 2020 | SNBP | Panbela Therapeuti ... | Schemel Donald Robert | Director | Grant | A | 0.00 | 2,875 | 0 | 92,303 | 89.4 K to 92.3 K (+3.21 %) |
| Dec 03 2020 | SNBP | Panbela Therapeuti ... | Fratamico Arthur | Director | Grant | A | 0.00 | 2,875 | 0 | 5,299 | 2.4 K to 5.3 K (+118.61 %) |
| Sep 14 2020 | SNBP | Sun BioPharma, Inc ... | Simpson Jennifer K. | President and CEO | Buy | P | 2.74 | 1,000 | 2,737 | 3,424 | 2.4 K to 3.4 K (+41.25 %) |
| Sep 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 2.55 | 225 | 574 | 159,420 | 159.2 K to 159.4 K (+0.14 %) |
| Sep 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 2.51 | 24,775 | 62,158 | 159,195 | 134.4 K to 159.2 K (+18.43 %) |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | P | 4.54 | 2,424 | 11,005 | 2,424 | |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Buy | P | 0.00 | 2,424 | 0 | 13,436 | 11 K to 13.4 K (+22.01 %) |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | P | 4.54 | 2,424 | 11,005 | 2,424 | |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Buy | P | 0.00 | 2,424 | 0 | 2,424 | 0 to 2.4 K |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Simpson Jennifer K. | President and CEO | Option Exercise | P | 4.54 | 2,424 | 11,005 | 2,424 | |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Simpson Jennifer K. | President and CEO | Buy | P | 0.00 | 2,424 | 0 | 2,424 | 0 to 2.4 K |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | P | 4.54 | 10,000 | 45,400 | 10,000 | |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Buy | P | 0.00 | 10,000 | 0 | 207,995 | 198 K to 208 K (+5.05 %) |
| Jul 17 2020 | SNBP | Sun BioPharma, Inc ... | Simpson Jennifer K. | President and CEO | Option Exercise | A | 9.99 | 212,048 | 2,118,360 | 212,048 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | A | 4.98 | 50,000 | 249,000 | 50,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 4.98 | 40,000 | 199,200 | 40,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | A | 4.98 | 50,000 | 249,000 | 50,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 4.98 | 40,000 | 199,200 | 40,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 4.98 | 32,000 | 159,360 | 32,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 4.98 | 12,000 | 59,760 | 12,000 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 4.98 | 13,700 | 68,226 | 13,700 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 4.98 | 13,700 | 68,226 | 13,700 | |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Option Exercise | A | 4.98 | 13,700 | 68,226 | 13,700 | |
| Jun 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | P | 6.00 | 10,000 | 60,000 | 10,000 | |
| Jun 09 2020 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 0.00 | 10,000 | 0 | 134,420 | 124.4 K to 134.4 K (+8.04 %) |
| Jun 09 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | P | 6.00 | 2,500 | 15,000 | 2,500 | |
| Jun 09 2020 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Buy | P | 0.00 | 2,500 | 0 | 11,012 | 8.5 K to 11 K (+29.37 %) |
| May 27 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | P | 6.00 | 10,000 | 60,000 | 10,000 | |
| May 27 2020 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Buy | P | 0.00 | 10,000 | 0 | 207,995 | 198 K to 208 K (+5.05 %) |
| Dec 23 2019 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 3.70 | 26,800 | 99,160 | 26,800 | |
| Dec 23 2019 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 3.70 | 6,500 | 24,050 | 6,500 | |
| Sep 26 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
| Sep 26 2019 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 5.00 | 25,000 | 125,000 | 25,000 | |
| Sep 26 2019 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 5.00 | 25,000 | 125,000 | 25,000 | |
| Sep 24 2019 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | P | 4.00 | 30,000 | 120,000 | 30,000 | |
| Sep 24 2019 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 0.00 | 30,000 | 0 | 124,420 | 94.4 K to 124.4 K (+31.77 %) |
| Sep 24 2019 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | P | 4.00 | 7,142 | 28,568 | 7,142 | |
| Sep 24 2019 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Buy | P | 0.00 | 7,142 | 0 | 8,142 | 1,000 to 8.1 K (+714.20 %) |
| Sep 04 2019 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | P | 4.00 | 1,428 | 5,712 | 1,428 | |
| Sep 04 2019 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Buy | P | 0.00 | 1,428 | 0 | 8,512 | 7.1 K to 8.5 K (+20.16 %) |
| Sep 04 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | P | 4.00 | 30,000 | 120,000 | 30,000 | |
| Sep 04 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Buy | P | 0.00 | 30,000 | 0 | 197,995 | 168 K to 198 K (+17.86 %) |
| Aug 26 2019 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Sell | S | 3.00 | 343,411 | 1,030,233 | 212,127 | 555.5 K to 212.1 K (-61.82 %) |
| Aug 26 2019 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Sell | S | 3.00 | 343,411 | 1,030,233 | 212,127 | 555.5 K to 212.1 K (-61.82 %) |
| Jul 02 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | C | 3.50 | 35,000 | 122,500 | 0 | |
| Jul 02 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Buy | C | 0.00 | 10,495 | 0 | 167,995 | 157.5 K to 168 K (+6.66 %) |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Option Exercise | A | 2.95 | 6,800 | 20,060 | 6,800 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Option Exercise | A | 2.95 | 27,000 | 79,650 | 27,000 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 6,800 | 20,060 | 6,800 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 2.95 | 27,000 | 79,650 | 27,000 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 2.95 | 6,800 | 20,060 | 6,800 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 2.95 | 27,000 | 79,650 | 27,000 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | A | 2.95 | 112,800 | 332,760 | 112,800 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Exec. Chairman, Pre ... | Option Exercise | A | 2.95 | 43,300 | 127,735 | 43,300 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 2.95 | 84,100 | 248,095 | 84,100 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 2.95 | 40,300 | 118,885 | 40,300 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 2.95 | 48,300 | 142,485 | 48,300 | |
| May 23 2019 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 2.95 | 9,500 | 28,025 | 9,500 | |
| Jan 24 2019 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | S | 5.00 | 47,025 | 235,125 | 0 | |
| Jan 24 2019 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Sell | S | 0.00 | 47,025 | 0 | 0 | 47 K to 0 (-100.00 %) |
| Oct 01 2018 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Option Exercise | G | 5.00 | 11,767 | 58,835 | 11,767 | |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Option Exercise | P | 5.00 | 1,000 | 5,000 | 1,000 | |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Buy | P | 0.00 | 1,000 | 0 | 51,000 | 50 K to 51 K (+2.00 %) |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | C | 5.00 | 11,756 | 58,780 | 11,756 | |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | C | 10.10 | 50,000 | 505,000 | 0 | |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | P | 5.00 | 5,000 | 25,000 | 5,000 | |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | C | 0.00 | 11,756 | 0 | 200,848 | 189.1 K to 200.8 K (+6.22 %) |
| Jun 14 2018 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 0.00 | 5,000 | 0 | 899,204 | 894.2 K to 899.2 K (+0.56 %) |
| May 29 2018 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | C | 5.00 | 47,025 | 235,125 | 47,025 | |
| May 29 2018 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | C | 10.10 | 200,000 | 2,020,000 | 0 | |
| May 29 2018 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Buy | C | 0.00 | 47,025 | 0 | 47,025 | 0 to 47 K |
| Apr 19 2018 | SNBP | Sun BioPharma, Inc ... | Horvath Susan | V.P. of Finance & C ... | Option Exercise | A | 5.75 | 40,000 | 230,000 | 40,000 | |
| Mar 08 2018 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 10.00 | 50,000 | 500,000 | 50,000 | |
| Mar 01 2018 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Option Exercise | A | 8.10 | 100,000 | 810,000 | 100,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Option Exercise | P | 5.00 | 5,000 | 25,000 | 5,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Buy | P | 0.00 | 5,000 | 0 | 194,576 | 189.6 K to 194.6 K (+2.64 %) |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | P | 5.00 | 3,000 | 15,000 | 3,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Buy | P | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Option Exercise | P | 5.00 | 1,000 | 5,000 | 1,000 | |
| Feb 22 2018 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Buy | P | 0.00 | 1,000 | 0 | 4,500 | 3.5 K to 4.5 K (+28.57 %) |
| Dec 15 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | M | 1.88 | 80,000 | 150,000 | 0 | |
| Dec 15 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Payment of Exercise | F | 13.03 | 11,512 | 150,001 | 555,538 | 567.1 K to 555.5 K (-2.03 %) |
| Dec 15 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Buy | M | 1.88 | 80,000 | 150,000 | 567,050 | 487.1 K to 567.1 K (+16.43 %) |
| Mar 29 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | D | 1.13 | 177,776 | 199,998 | 0 | |
| Mar 29 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | D | 1.13 | 444,444 | 500,000 | 0 | |
| Mar 29 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Grant | A | 0.75 | 280,000 | 210,000 | 280,000 | 0 to 280 K |
| Mar 29 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Grant | A | 0.75 | 700,000 | 525,000 | 4,870,508 | 4.2 M to 4.9 M (+16.78 %) |
| Mar 21 2017 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Option Exercise | A | 1.51 | 248,000 | 374,480 | 424,000 | |
| Mar 21 2017 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Option Exercise | A | 1.51 | 93,000 | 140,430 | 159,000 | |
| Mar 21 2017 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 1.01 | 50,000 | 50,500 | 50,000 | |
| Mar 21 2017 | SNBP | Sun BioPharma, Inc ... | GILBERTSON RYAN RANDALL | 10% Owner | Option Exercise | A | 1.01 | 200,000 | 202,000 | 200,000 | |
| Dec 29 2016 | SNBP | Sun BioPharma, Inc ... | Gill Dalvir S | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Option Exercise | A | 1.51 | 150,000 | 226,500 | 150,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | A | 1.51 | 150,000 | 226,500 | 150,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | MATHIESEN JEFFREY S | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | PAULSON J ROBERT JR | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 1.51 | 160,000 | 241,600 | 160,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | A | 1.51 | 208,000 | 314,080 | 208,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Option Exercise | A | 1.51 | 176,000 | 265,760 | 176,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Option Exercise | A | 1.51 | 250,000 | 377,500 | 250,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Option Exercise | A | 1.51 | 66,000 | 99,660 | 66,000 | |
| Dec 14 2016 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Option Exercise | A | 1.51 | 150,000 | 226,500 | 150,000 | |
| Dec 01 2016 | SNBP | Sun BioPharma, Inc ... | Schemel Donald Robert | Director | Sell | S | 1.43 | 7,000 | 10,010 | 2,826,548 | 2.8 M to 2.8 M (-0.25 %) |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Option Exercise | P | 1.50 | 15,000 | 22,500 | 415,000 | |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Gagnon Suzanne | Director | Buy | P | 0.00 | 30,000 | 0 | 430,000 | 400 K to 430 K (+7.50 %) |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Option Exercise | P | 1.50 | 25,000 | 37,500 | 25,000 | |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | KAYSEN DAVID B | President and CEO | Buy | P | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Option Exercise | P | 1.50 | 17,500 | 26,250 | 17,500 | |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Kellen Scott | Chief Financial Off ... | Buy | P | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Option Exercise | P | 1.50 | 25,000 | 37,500 | 25,000 | |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Cullen Michael T. | Executive Chairman | Buy | P | 0.00 | 50,000 | 0 | 1,895,764 | 1.8 M to 1.9 M (+2.71 %) |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Option Exercise | P | 1.50 | 50,000 | 75,000 | 50,000 | |
| Jun 28 2016 | SNBP | Sun BioPharma, Inc ... | Schaffer Paul W. | Director | Buy | P | 0.00 | 100,000 | 0 | 189,092 | 89.1 K to 189.1 K (+112.24 %) |
| Nov 10 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | S | 0.00 | 216,705 | 0 | 74,825 | 291.5 K to 74.8 K (-74.33 %) | |
| Nov 10 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | Sell | S | 0.00 | 300,561 | 0 | 158,175 | 458.7 K to 158.2 K (-65.52 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Buy | P | 0.10 | 100,060 | 10,006 | 100,060 | 0 to 100.1 K | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Buy | J | 0.00 | 195,473 | 0 | 291,530 | 96.1 K to 291.5 K (+203.50 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | J | 0.00 | 195,473 | 0 | 0 | 195.5 K to 0 (-100.00 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Grant | A | 0.01 | 120,000 | 1,200 | 195,473 | 75.5 K to 195.5 K (+159.00 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | S | 13.54 | 23,943 | 324,188 | 96,057 | 120 K to 96.1 K (-19.95 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | S | 13.54 | 18,813 | 254,728 | 75,473 | 94.3 K to 75.5 K (-19.95 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Buy | J | 0.00 | 120,000 | 0 | 120,000 | 0 to 120 K | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | J | 0.00 | 120,000 | 0 | 94,286 | 214.3 K to 94.3 K (-56.00 %) | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Buy | J | 0.00 | 214,286 | 0 | 214,286 | 0 to 214.3 K | |
| May 26 2015 | SNBP | Sun BioPharma, Inc ... | Sargent Robert John | Sell | J | 0.00 | 120 | 0 | 0 | 120 to 0 (-100.00 %) | |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Buy | P | 0.10 | 100,060 | 10,006 | 100,060 | 0 to 100.1 K |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Grant | A | 0.01 | 180,000 | 1,800 | 458,736 | 278.7 K to 458.7 K (+64.58 %) |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Sell | S | 13.54 | 69,478 | 940,732 | 278,736 | 348.2 K to 278.7 K (-19.95 %) |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Buy | J | 0.00 | 348,214 | 0 | 348,214 | 0 to 348.2 K |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Sell | J | 0.00 | 195 | 0 | 0 | 195 to 0 (-100.00 %) |
| May 19 2015 | SNBP | Sun BioPharma, Inc ... | Fuhrman David Michael | President and CEO | Buy | J | 1,000.00 | 50 | 50,000 | 195 | 145 to 195 (+34.48 %) |
Page: 1